SEC Form 4 · accession 0001645627-17-000086
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
Jun 26, 2017
Accepted (ET)
Jun 29, 2017 · 10:58 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 26, 2017 | P | 2,000 | $0.0518 | A | 21,339,349 | D | |
| Common Stock | Jun 26, 2017 | P | 2,000 | $0.0513 | A | 21,341,349 | D | |
| Common Stock | Jun 26, 2017 | P | 1,000 | $0.0518 | A | 21,342,349 | D | |
| Common Stock | Jun 26, 2017 | P | 2,000 | $0.0514 | A | 21,344,349 | D | |
| Common Stock | Jun 26, 2017 | P | 2,000 | $0.0479 | A | 21,346,349 | D | |
| Common Stock | Jun 26, 2017 | P | 2,000 | $0.0479 | A | 21,348,349 | D | |
| Common Stock | Jun 27, 2017 | P | 1,000 | $0.049 | A | 21,349,349 | D | |
| Common Stock | Jun 27, 2017 | P | 1,000 | $0.048 | A | 21,350,349 | D | |
| Common Stock | Jun 27, 2017 | P | 1,000 | $0.0479 | A | 21,351,349 | D | |
| Common Stock | Jun 27, 2017 | P | 2,000 | $0.0479 | A | 21,353,349 | D | |
| Common Stock | Jun 28, 2017 | P | 2,000 | $0.043 | A | 21,355,349 | D | |
| Common Stock | Jun 28, 2017 | P | 2,000 | $0.042 | A | 21,357,349 | D | |
| Common Stock | Jun 28, 2017 | P | 2,000 | $0.042 | A | 21,359,349 | D | |
| Common Stock | Jun 28, 2017 | P | 2,000 | $0.042 | A | 21,361,349 | D | |
| Common Stock | Jun 28, 2017 | P | 2,000 | $0.0438 | A | 21,363,349 | D | |
| Common Stock | Jun 28, 2017 | P | 2,000 | $0.0439 | A | 21,365,349 | D |
Table II — derivative securities
No Table II lines on this filing.